MDL | MFCD00056058 |
---|---|
Molecular Weight | 244.22 |
Molecular Formula | C10H13FN2O4 |
SMILES | O=C(N1)N([C@H]2C[C@H](F)[C@@H](CO)O2)C=C(C)C1=O |
NCT Number | Sponsor | Condition | Start Date | Phase |
---|---|---|---|---|
NCT00002254 | Lederle Laboratories|NIH AIDS Clinical Trials Information Service |
HIV Infections
|
Not Applicable | |
NCT00002271 | Lederle Laboratories|NIH AIDS Clinical Trials Information Service |
HIV Infections
|
Not Applicable | |
NCT00002260 | Lederle Laboratories|NIH AIDS Clinical Trials Information Service |
HIV Infections
|
Not Applicable | |
NCT02232581 | Boehringer Ingelheim |
HIV Infections
|
April 2004 | Phase 2 |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : 125 mg/mL ( 511.83 mM ; Need ultrasonic)
H 2 O : ≥ 25 mg/mL ( 102.37 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 4.0947 mL | 20.4733 mL | 40.9467 mL |
5 mM | 0.8189 mL | 4.0947 mL | 8.1893 mL |
10 mM | 0.4095 mL | 2.0473 mL | 4.0947 mL |